Chest
-
DVT/PE PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To outline the resource use and costs a U.S. health plan can anticipate during the evaluation and first year of treatment of a CTEPH patient ⋯ Vijay Joish: Employee: employee of bayer sponsor of study Christine Divers: Employee: employee of bayer sponsor of study Chakkarin CBurudpakdee: Consultant fee, speaker bureau, advisory committee, etc.: consultant of bayer sponsor of study Anshul Shah: Consultant fee, speaker bureau, advisory committee, etc.: consultant of bayer sponsor of study Stephen Mathai: Consultant fee, speaker bureau, advisory committee, etc.: consultant to bayer sponsor of studyNo Product/Research Disclosure Information.
-
Bronchology Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Pulmonary aspergilloma is an intractable disease characterized by growth of the Aspergillus fungus to form fungus balls in preformed cavitary lesions of the lungs. Complete elimination of the fungus balls cannot be accomplished by antifungal treatment alone, and surgical pneumonectomy is recommended. We report two cases in which cavernostomy was performed because of recurrent infections of the residual lung and hemoptysis after operation for lung cancer. ⋯ The following authors have nothing to disclose: Ryo Takahashi, Michio Fujino, Taiki Fujiwara, Hisami YamakawaNo Product/Research Disclosure Information.
-
Respiratory InfectionsSESSION TYPE: Slide PresentationsPRESENTED ON: Sunday, March 23, 2014 at 04:15 PM - 05:15 PMPURPOSE: Community-acquired MRSA (CA-MRSA) pneumonia is an uncommon but potentially life-threatening disease. MRSA is generally not covered when treating CAP. Several small case series have described these patients. Certain clinical characteristics have been proposed that suggest MRSA as a pathogen. However, when to consider CA-MRSA is a subject of ongoing debate. The current study reviewed the risk factors, presentation, and outcomes of patients with CA-MRSA pneumonia in an urban community hospital. ⋯ The following authors have nothing to disclose: Kunal Patel, Viral Patel, Kelly Cervellione, Craig ThurmNo Product/Research Disclosure Information.
-
COPD PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Acute exacerbations (AEs) have a negative impact on various aspects of the progression of COPD, but objective and detailed data on the impact of hospitalizations for an AE are needed. This study was designed to evaluate the effects of hospitalization on multiple functional parameters in adults with acute exacerbation of COPD. ⋯ The following authors have nothing to disclose: Marie Carmen Valenza, Maria José Flores-Barba, Gerald Valenza-Demet, Irene Torres-Sánchez, Irene Cabrera-Martos, Angela Ruiz-SaezNo Product/Research Disclosure Information.
-
Asthma Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Management of status asthmaticus requires more than guidelines-guided therapy. Occasionally, unusual therapeutic interventions may provide significant benefits. The role of bronchoscopy in fatal asthma is still not clearly defined. ⋯ The following authors have nothing to disclose: Muhammad Khan, Hadil Al Otair, Abdul Aziz AlZeer, Alaa ElgishyNo Product/Research Disclosure Information.